Patient-reported outcomes in adults with moderate to severe asthma after use of budesonide and formoterol administered via 1 pressurized metered-dose inhaler
- 30 November 2008
- journal article
- research article
- Published by Elsevier BV in Annals of Allergy, Asthma & Immunology
- Vol. 101 (5), 463-473
- https://doi.org/10.1016/s1081-1206(10)60284-0
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Efficacy and Safety of Budesonide and Formoterol in One Pressurised Metered-Dose Inhaler in Adults and Adolescents with Moderate to Severe AsthmaDrugs, 2006
- Traditional and patient-centred outcomes with three classes of asthma medicationEuropean Respiratory Journal, 2005
- Clinically Important Improvements in Asthma-Specific Quality of Life, But No Difference in Conventional Clinical Indexes in Patients Changed From Conventional Beclomethasone Dipropionate to Approximately Half the Dose of Extrafine Beclomethasone DipropionateSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2002
- A new treatment satisfaction measure for asthmatics: A validation studyQuality of Life Research, 2000
- Asthma quality of life during 1 year of treatment with budesonide with or without formoterolEuropean Respiratory Journal, 1999
- The Influence of an Inhaled Steroid on Quality of Life in Patients With Asthma or COPDSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1995
- Quality of life in asthma clinical trials: comparison of salmeterol and salbutamol.American Journal of Respiratory and Critical Care Medicine, 1995
- Determining a minimal important change in a disease-specific quality of life questionnaireJournal of Clinical Epidemiology, 1994
- Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials.Thorax, 1992
- Statement on Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease (COPD) and AsthmaAmerican Review of Respiratory Disease, 1987